It is a known fact that the 1990s brought a decrease in mortality after myocardial infarction in Sweden but that differences in mortality rates following myocardial infarction still remain between the Swedish counties. Unresolved, however, are questions as to what these inter-county differences mean for the individual patient and what role hospital care plays in this context. We analysed all patients aged 64-85 years who were hospitalised following diagnosis of myocardial infarction in Sweden during the period 1993-1996. To gain an understanding of the relevance of geographical differences in mortality after myocardial infarction for the individual patient we applied multi-level regression analysis and calculated county and hospital median ...
SummaryBackgroundInternational research for acute myocardial infarction lacks comparisons of whole h...
Malmö (pop. 250 000) is a city in the south of Sweden where there are marked intra-urban differences...
The development of new evidence based diagnostic methods, drugs, interventions and medical devices i...
It is a known fact that the 1990s brought a decrease in mortality after myocardial infarction in Swe...
It is a known fact that the 1990s brought a decrease in mortality after myocardial infarction in Swe...
In this study, the geographical variation of the mortality rate in mid-Sweden was studied. Data on m...
Objective. To study to what extent geographical differences of the mortality from ischaemic heart di...
Morbidity and mortality in cardiovascular diseases (CVD) can be described as an ongoing epidemic, al...
<div><p>Background</p><p>In 1988, a cardiovascular prevention program which combined an individual a...
In Stockholm county, a rapid decline in mortality from acute myocardial infarction (AMI) was observe...
In 2006, ischaemic heart disease (IHD) accounted for 18 % in women and 21 % in men of all deaths in ...
Mortality following hospital treatment in Finland and Norway is similar for major diseases, with acu...
Background. Regional variations in mortality and morbidity have been shown in Europe and USA. Longit...
AIMS: In western countries out-of-hospital ischaemic heart disease (IHD) deaths account for approxim...
OBJECTIVE To assess the between hospital variation in use of guideline recommended treatments and cl...
SummaryBackgroundInternational research for acute myocardial infarction lacks comparisons of whole h...
Malmö (pop. 250 000) is a city in the south of Sweden where there are marked intra-urban differences...
The development of new evidence based diagnostic methods, drugs, interventions and medical devices i...
It is a known fact that the 1990s brought a decrease in mortality after myocardial infarction in Swe...
It is a known fact that the 1990s brought a decrease in mortality after myocardial infarction in Swe...
In this study, the geographical variation of the mortality rate in mid-Sweden was studied. Data on m...
Objective. To study to what extent geographical differences of the mortality from ischaemic heart di...
Morbidity and mortality in cardiovascular diseases (CVD) can be described as an ongoing epidemic, al...
<div><p>Background</p><p>In 1988, a cardiovascular prevention program which combined an individual a...
In Stockholm county, a rapid decline in mortality from acute myocardial infarction (AMI) was observe...
In 2006, ischaemic heart disease (IHD) accounted for 18 % in women and 21 % in men of all deaths in ...
Mortality following hospital treatment in Finland and Norway is similar for major diseases, with acu...
Background. Regional variations in mortality and morbidity have been shown in Europe and USA. Longit...
AIMS: In western countries out-of-hospital ischaemic heart disease (IHD) deaths account for approxim...
OBJECTIVE To assess the between hospital variation in use of guideline recommended treatments and cl...
SummaryBackgroundInternational research for acute myocardial infarction lacks comparisons of whole h...
Malmö (pop. 250 000) is a city in the south of Sweden where there are marked intra-urban differences...
The development of new evidence based diagnostic methods, drugs, interventions and medical devices i...